J Korean Neuropsychiatr Assoc.  2012 Jan;51(1):4-15. 10.4306/jknpa.2012.51.1.4.

Clinical Case Conference

• Park HY
• Kim JH
• Yoon SC

• KMID: 2194676
• DOI: http://doi.org/10.4306/jknpa.2012.51.1.4

Abstract

No abstract available.

Figure

• 

  Fig. 1 Brain MRI finding of case 3 at the time of 'lung cancer' diagnosis.

• 

  Fig. 2 Brain MRI finding of case 3 at follow-up : 3 years after initial diagnosis.

Reference

1. Smith SK, Zimmerman S, Williams CS, Preisser JS, Clipp EC. Post-traumatic stress outcomes in non-Hodgkin's lymphoma survivors. J Clin Oncol. 2008. 26:934–941.

2. Smith SK, Zimmerman S, Williams CS, Benecha H, Abernethy AP, Mayer DK, et al. Post-traumatic stress symptoms in long-term non-Hodgkin's lymphoma survivors: does time heal? J Clin Oncol. 2011. 29:4526–4533.

3. Varela VS, Ng A, Mauch P, Recklitis CJ. Posttraumatic stress disorder (PTSD) in survivors of Hodgkin's lymphoma: prevalence of PTSD and partial PTSD compared with sibling controls. Psychooncology. 2011. Epub ahead of print.

4. Baker F, Marcellus D, Zabora J, Polland A, Jodrey D. Psychological distress among adult patients being evaluated for bone marrow transplantation. Psychosomatics. 1997. 38:10–19.

5. Syrjala KL, Langer S, Abrams J, Storer B, Martin P. Physical and mental recovery after hematopoietic stem cell transplantation. Discov Med. 2004. 4:263–269.

6. Duijts SF, Zeegers MP, Borne BV. The association between stressful life events and breast cancer risk: a meta-analysis. Int J Cancer. 2003. 107:1023–1029.

7. Price MA, Tennant CC, Smith RC, Butow PN, Kennedy SJ, Kossoff MB, et al. The role of psychosocial factors in the development of breast carcinoma: Part I. The cancer prone personality. Cancer. 2001. 91:679–685.

8. Reynolds P, Hurley S, Torres M, Jackson J, Boyd P, Chen VW. Use of coping strategies and breast cancer survival: results from the Black/White Cancer Survival Study. Am J Epidemiol. 2000. 152:940–949.

9. Spiegel D, Bloom JR, Kraemer HC, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet. 1989. 2:888–891.

10. Gill KM, Mishel M, Belyea M, Germino B, Germino LS, Porter L, et al. Triggers of uncertainty about recurrence and long-term treatment side effects in older African American and Caucasian breast cancer survivors. Oncol Nurs Forum. 2004. 31:633–639.

11. Kelly CM, Juurlink DN, Gomes T, Duong-Hua M, Pritchard KI, Austin PC, et al. Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study. BMJ. 2010. 340:c693.

12. Joensuu G, Joensuu T, Nupponen N, Ruutu M, Collan J, Pesonen S, et al. A phase II trial of gefitinib in patients with rising PSA following radical prostatectomy or radiotherapy. Acta Oncol. 2012. 51:130–133.

13. Shaw EG, Rosdhal R, D'Agostino RB Jr, Lovato J, Naughton MJ, Robbins ME, et al. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol. 2006. 24:1415–1420.

14. Meyers CA, Weitzner MA, Valentine AD, Levin VA. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol. 1998. 16:2522–2527.

15. Butler JM Jr, Case LD, Atkins J, Frizzell B, Sanders G, Griffin P, et al. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. Int J Radiat Oncol Biol Phys. 2007. 69:1496–1501.